Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 18901 - 18925 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Copper	Approved Investigational	NLRC4	58484	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NLRC4 mRNA	2p22.3	A21749
Copper	Approved Investigational	NLRP1	22861	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NLRP1 mRNA	17p13	A21749
Copper	Approved Investigational	NME1-NME2	654364	downregulated	[Disulfiram binds to Copper] which results in decreased expression of NME1-NME2 mRNA	17q21.33	A21750
Copper	Approved Investigational	NME4	4833	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NME4 mRNA	16p13.3	A21749
Copper	Approved Investigational	NMNAT2	23057	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NMNAT2 mRNA	1q25.3	A21749
Copper	Approved Investigational	NMU	10874	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NMU mRNA	4q12	A21749
Copper	Approved Investigational	NNMT	4837	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NNMT mRNA	11q23.1	A21749
Copper	Approved Investigational	NOG	9241	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NOG mRNA	17q22	A21749
Copper	Approved Investigational	NOL12	79159	downregulated	[Disulfiram binds to Copper] which results in decreased expression of NOL12 mRNA	22q13.1	A21750
Copper	Approved Investigational	NOL3	8996	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NOL3 mRNA	16q22.1	A21749
Copper	Approved Investigational	NOP56	10528	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NOP56 mRNA	20p13	A21749
Copper	Approved Investigational	NOS1	4842	upregulated	Copper results in increased expression of NOS1 mRNA	12q24.22	A21757
Copper	Approved Investigational	NOS2	4843	upregulated	Copper results in increased expression of NOS2 mRNA	17q11.2	A21757
Copper	Approved Investigational	NOSIP	51070	downregulated	[Disulfiram binds to Copper] which results in decreased expression of NOSIP mRNA	19q13.33	A21750
Copper	Approved Investigational	NPC1	4864	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NPC1 mRNA	18q11.2	A21749
Copper	Approved Investigational	NPC2	10577	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NPC2 mRNA	14q24.3	A21749
Copper	Approved Investigational	NPEPL1	79716	upregulated	[Disulfiram binds to Copper] which results in increased expression of NPEPL1 mRNA	20q13.32	A21750
Copper	Approved Investigational	NPNT	255743	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NPNT mRNA	4q24	A21749
Copper	Approved Investigational	NPPB	4879	upregulated	Copper results in increased expression of NPPB mRNA	1p36.22	A21752
Copper	Approved Investigational	NPPB	4879	downregulated	[Disulfiram binds to Copper] which results in decreased expression of NPPB mRNA	1p36.22	A21750
Copper	Approved Investigational	NPR3	4883	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NPR3 mRNA	5p13.3	A21749
Copper	Approved Investigational	NPTX2	4885	downregulated	[Disulfiram binds to Copper] which results in decreased expression of NPTX2 mRNA	7q22.1	A21750
Copper	Approved Investigational	NR1D2	9975	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NR1D2 mRNA	3p24.2	A21749
Copper	Approved Investigational	NR1H4	9971	upregulated	[NSC 689534 binds to Copper] which results in increased expression of NR1H4 mRNA	12q23.1	A21749
Copper	Approved Investigational	NR2F1	7025	downregulated	[NSC 689534 binds to Copper] which results in decreased expression of NR2F1 mRNA	5q15	A21749

Displaying entries 18901 - 18925 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability